FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297487923> ?p ?o ?g. }

• W4297487923 endingPage "749" @default.
• W4297487923 startingPage "742" @default.
• W4297487923 abstract "The use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is the first line treatment for EGFR-mutant advanced non-small cell lung cancer (NSCLC), but drug resistance will be acquired within 1-2 years, and the following treatment efficacy is poor. The invention of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors has dramatically changed the situation of tumor treatment. PD-1/PD-L1 inhibitors are less effective in patients with NSCLC harboring EGFR mutation. It is a challenge to make patients with EGFR-mutated advanced NSCLC benefit from anti-PD-1/PD-L1 therapy. In this paper, the research progress on the impact of EGFR mutation on the immune status of NSCLC and related clinical studies in recent 5 years are reviewed. .【中文题目：EGFR突变的晚期非小细胞肺癌的 抗PD-1/PD-L1治疗研究进展】 【中文摘要：表皮生长因子受体（epidermal growth factor receptor, EGFR）酪氨酸激酶抑制剂（tyrosine kinase inhibitor, TKI）是EGFR突变的晚期非小细胞肺癌（non-small cell lung cancer, NSCLC）的一线治疗方案，但1年-2年内会出现耐药，后续治疗效果差。程序性死亡受体1（programmed cell death 1, PD-1）/程序性死亡配体1（programmed cell death ligand 1, PD-L1）抑制剂的出现极大地改变了肿瘤治疗的格局。然而，单药抗PD-1/PD-L1对EGFR突变的晚期NSCLC低应答或无应答，如何使EGFR突变的晚期NSCLC患者从抗PD-1/PD-L1治疗中获益是需要攻克的难关。本文主要就近5年来EGFR突变对NSCLC免疫状态影响的研究进展及相关的临床研究进行综述。 】 【中文关键词：肺肿瘤；免疫治疗；肿瘤微环境】." @default.
• W4297487923 created "2022-09-29" @default.
• W4297487923 creator A5034651914 @default.
• W4297487923 creator A5051345076 @default.
• W4297487923 date "2022-10-20" @default.
• W4297487923 modified "2023-09-29" @default.
• W4297487923 title "[Research Progress of Anti-PD-1/PD-L1 Therapy for Non-small Cell Lung Cancer 
with EGFR Mutation]." @default.
• W4297487923 cites W2131950300 @default.
• W4297487923 cites W2337836619 @default.
• W4297487923 cites W2547310148 @default.
• W4297487923 cites W2578528809 @default.
• W4297487923 cites W2773935447 @default.
• W4297487923 cites W2782863308 @default.
• W4297487923 cites W2783897381 @default.
• W4297487923 cites W2803642760 @default.
• W4297487923 cites W2805354595 @default.
• W4297487923 cites W2898682581 @default.
• W4297487923 cites W2899537738 @default.
• W4297487923 cites W2912107322 @default.
• W4297487923 cites W2916877067 @default.
• W4297487923 cites W2918948206 @default.
• W4297487923 cites W2921086774 @default.
• W4297487923 cites W2922107046 @default.
• W4297487923 cites W2924359886 @default.
• W4297487923 cites W2938898812 @default.
• W4297487923 cites W2940771671 @default.
• W4297487923 cites W2946166987 @default.
• W4297487923 cites W2949623164 @default.
• W4297487923 cites W2985245838 @default.
• W4297487923 cites W2991567947 @default.
• W4297487923 cites W2991861115 @default.
• W4297487923 cites W2999583889 @default.
• W4297487923 cites W3001408868 @default.
• W4297487923 cites W3003556485 @default.
• W4297487923 cites W3007051114 @default.
• W4297487923 cites W3008955224 @default.
• W4297487923 cites W3015756332 @default.
• W4297487923 cites W3034135833 @default.
• W4297487923 cites W3043779129 @default.
• W4297487923 cites W3083619616 @default.
• W4297487923 cites W3092997330 @default.
• W4297487923 cites W3098529833 @default.
• W4297487923 cites W3111757284 @default.
• W4297487923 cites W3124204822 @default.
• W4297487923 cites W3128294524 @default.
• W4297487923 cites W3128646645 @default.
• W4297487923 cites W3131416308 @default.
• W4297487923 cites W3135137395 @default.
• W4297487923 cites W3150255284 @default.
• W4297487923 cites W3152809041 @default.
• W4297487923 cites W3154545126 @default.
• W4297487923 cites W3157623590 @default.
• W4297487923 cites W3166554822 @default.
• W4297487923 cites W3167891114 @default.
• W4297487923 cites W3184352851 @default.
• W4297487923 cites W3189911105 @default.
• W4297487923 cites W3197315082 @default.
• W4297487923 cites W3199096994 @default.
• W4297487923 cites W3203663460 @default.
• W4297487923 cites W3207277076 @default.
• W4297487923 cites W4200151387 @default.
• W4297487923 cites W4210394199 @default.
• W4297487923 cites W4210459869 @default.
• W4297487923 cites W4283722016 @default.
• W4297487923 cites W4288459215 @default.
• W4297487923 cites W3040063576 @default.
• W4297487923 doi "https://doi.org/10.3779/j.issn.1009-3419.2022.101.44" @default.
• W4297487923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36167460" @default.
• W4297487923 hasPublicationYear "2022" @default.
• W4297487923 type Work @default.
• W4297487923 citedByCount "0" @default.
• W4297487923 crossrefType "journal-article" @default.
• W4297487923 hasAuthorship W4297487923A5034651914 @default.
• W4297487923 hasAuthorship W4297487923A5051345076 @default.
• W4297487923 hasConcept C121608353 @default.
• W4297487923 hasConcept C126322002 @default.
• W4297487923 hasConcept C143998085 @default.
• W4297487923 hasConcept C170493617 @default.
• W4297487923 hasConcept C2776256026 @default.
• W4297487923 hasConcept C2777506169 @default.
• W4297487923 hasConcept C2777701055 @default.
• W4297487923 hasConcept C2779438470 @default.
• W4297487923 hasConcept C2781053074 @default.
• W4297487923 hasConcept C42362537 @default.
• W4297487923 hasConcept C502942594 @default.
• W4297487923 hasConcept C71924100 @default.
• W4297487923 hasConceptScore W4297487923C121608353 @default.
• W4297487923 hasConceptScore W4297487923C126322002 @default.
• W4297487923 hasConceptScore W4297487923C143998085 @default.
• W4297487923 hasConceptScore W4297487923C170493617 @default.
• W4297487923 hasConceptScore W4297487923C2776256026 @default.
• W4297487923 hasConceptScore W4297487923C2777506169 @default.
• W4297487923 hasConceptScore W4297487923C2777701055 @default.
• W4297487923 hasConceptScore W4297487923C2779438470 @default.
• W4297487923 hasConceptScore W4297487923C2781053074 @default.
• W4297487923 hasConceptScore W4297487923C42362537 @default.
• W4297487923 hasConceptScore W4297487923C502942594 @default.
• W4297487923 hasConceptScore W4297487923C71924100 @default.

• next